Spiro Medical is a clinical-stage medical device company exploring neuromodulation therapies for severe respiratory conditions.
Spiro Medical is dedicated to transforming the lives of patients with severe, uncontrolled asthma through pioneering neuromodulation technology.
We believe that by targeting the neurological underpinnings of respiratory disease, we can provide meaningful, long-lasting relief for patients who have exhausted conventional treatment options.
Our team combines deep clinical expertise, engineering excellence, and rigorous scientific methodology to advance a new standard of care in respiratory medicine.
World-class expertise in medical devices, respiratory medicine, and neuromodulation technology.
Backed by leading healthcare investors committed to transformative medical technologies.
Andera Partners
Omega Funds
Sherpa Healthcare Partners
HSG
NLVC
Hero Enterprise
SuperNova Invest
Explore collaboration opportunities, investment inquiries, or learn more about our clinical development program.
